Zacks Investment Research Downgrades IntriCon Corp. (IIN) to Sell
IntriCon Corp. (NASDAQ:IIN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Thursday.
According to Zacks, “IntriCon designs, develops, engineers and manufactures microminiaturized medical and electronic products. The Company supplies microminiaturized components, systems and molded plastic parts, primarily to the hearing instrument manufacturing industry, as well as the computer, government, electronics, telecommunications and medical equipment industries. The Company has facilities in the United States, Asia and Europe. “
IntriCon Corp. (NASDAQ:IIN) opened at 6.50 on Thursday. The stock has a 50 day moving average price of $6.00 and a 200 day moving average price of $5.27. The company’s market cap is $44.17 million. IntriCon Corp. has a 1-year low of $4.12 and a 1-year high of $8.02.
IntriCon Corp. (NASDAQ:IIN) last announced its quarterly earnings data on Monday, November 14th. The company reported ($0.19) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.10) by $0.09. IntriCon Corp. had a negative return on equity of 7.43% and a negative net margin of 2.82%. The firm had revenue of $16 million for the quarter, compared to analyst estimates of $16.82 million. Equities analysts forecast that IntriCon Corp. will post ($0.10) earnings per share for the current year.
Hedge funds have recently made changes to their positions in the company. Pacific Alternative Asset Management Company LLC purchased a new stake in shares of IntriCon Corp. during the third quarter valued at $630,000. Heartland Advisors Inc. raised its stake in shares of IntriCon Corp. by 1.4% in the third quarter. Heartland Advisors Inc. now owns 405,591 shares of the company’s stock valued at $2,346,000 after buying an additional 5,591 shares during the last quarter. Coe Capital Management LLC purchased a new stake in shares of IntriCon Corp. during the second quarter valued at $240,000. Bard Associates Inc. purchased a new stake in shares of IntriCon Corp. during the second quarter valued at $211,000. Finally, AWM Investment Company Inc. purchased a new stake in shares of IntriCon Corp. during the second quarter valued at $294,000. 23.46% of the stock is currently owned by institutional investors.
About IntriCon Corp.
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
Receive News & Stock Ratings for IntriCon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Corp. and related stocks with our FREE daily email newsletter.